Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 20/20 | 0.64 |
| ▸ | CDK9 | P50750 | 20/20 | 0.64 |
| ▸ | CDK4 | P11802 | 6/20 | 0.64 |
| ▸ | CCND1 | P24385 | 6/20 | 0.64 |
| ▸ | CDK2 | P24941 | 5/20 | 0.64 |
| ▸ | CCNA1 | P78396 | 5/20 | 0.64 |
| ▸ | CDK1 | P06493 | 4/20 | 0.64 |
| ▸ | CCNA2 | P20248 | 4/20 | 0.64 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.64 |
| ▸ | CDK3 | Q00526 | 4/20 | 0.64 |
| ▸ | CDK7 | P50613 | 4/20 | 0.64 |
| ▸ | CCNH | P51946 | 4/20 | 0.64 |
| ▸ | CDK6 | Q00534 | 2/20 | 0.64 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.64 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.64 |
| ▸ | CCNK | O75909 | 1/20 | 0.64 |
| ▸ | CDK14 | O94921 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CCNC | P24863 | 1/20 | 0.64 |
| ▸ | CDK17 | Q00537 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25477270 | 0.93 | CDK9 (0.68) | CCNT1CDK9CDK4CCND1CDK2 | |
| SCHEMBL25477265 | 0.88 | CDK9 (0.61) | CCNT1CDK9CDK4CCND1CDK2 | |
| SCHEMBL25482585 | 0.86 | CDK9 (0.52) | CCNT1CDK9CDK4CCND1CDK2 | |
| SCHEMBL25477310 | 0.86 | CDK9 (0.64) | CCNT1CDK9CDK4CCND1CDK2 | |
| SCHEMBL25477305 | 0.81 | CCNT1 (0.65) | CCNT1CDK9CDK4CCND1CDK2 | |
| SCHEMBL24418611 | 0.81 | CCNT1 (0.78) | CCNT1CDK9CDK4CCND1CDK2 | |
| SCHEMBL25477289 | 0.81 | CCNT1 (0.64) | CCNT1CDK9CDK4CCND1CDK2 | |
| SCHEMBL25477162 | 0.79 | CCNT1 (0.61) | CCNT1CDK9CDK4CCND1CDK2 | |
| SCHEMBL25479233 | 0.78 | CCNT1 (0.74) | CCNT1CDK9CDK4CCND1CDK2 | |
| SCHEMBL25477268 | 0.78 | CDK9 (0.68) | CCNT1CDK9CDK4CCND1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158159-A1 | CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158159-A1 | CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES THEREOF | CDK9, CDK19, CRBN | CCNT1 81/4885CDK9 1/4885CDK4 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.